{"DataElement":{"publicId":"6680223","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor AJCC Edition 8 Clinical T Category","preferredDefinition":"Extent of the primary pancreatic neuroendocrine tumor based on clinical findings using AJCC Ed. 8 criteria.","longName":"PNET_AJC8_CLN_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6679312","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Clinical T Category","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"5528371v1.0:2207100v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"5528371","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas","longName":"C27720","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4F7E4E-56D6-7FA1-E053-F662850AC326","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"ONEDATA","dateModified":"2016-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"849B24C4-16E4-1DFD-E053-F662850AF017","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 3/21/19 curated for AJCC ed. 8 content; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6680049","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to well-differentiated neuroendocrine tumors arising in the pancreas. It does not apply to carcinomas of the pancreas, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6680049v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Pancreatic Neuroendocrine Tumor pT4 TNM Finding v8","ValueMeaning":{"publicId":"6680051","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pT4 TNM Finding v8","longName":"6680051","preferredDefinition":"Pancreatic neuroendocrine tumor invading adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pT4 TNM Finding v8","conceptCode":"C135555","definition":"Pancreatic neuroendocrine tumor invading adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DD71-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849CC52A-DD8A-3313-E053-F662850A9A54","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"T3","valueDescription":"Pancreatic Neuroendocrine Tumor pT3 TNM Finding v8","ValueMeaning":{"publicId":"6680053","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pT3 TNM Finding v8","longName":"6680053","preferredDefinition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring more than 4 cm; or tumor invading the duodenum or bile duct. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pT3 TNM Finding v8","conceptCode":"C135554","definition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring more than 4 cm; or tumor invading the duodenum or bile duct. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DD97-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849CC52A-DDB0-3313-E053-F662850A9A54","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"T2","valueDescription":"Pancreatic Neuroendocrine Tumor pT2 TNM Finding v8","ValueMeaning":{"publicId":"6680055","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pT2 TNM Finding v8","longName":"6680055","preferredDefinition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring 2-4 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pT2 TNM Finding v8","conceptCode":"C135553","definition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring 2-4 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DDBD-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849CC52A-DDD6-3313-E053-F662850A9A54","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"T1","valueDescription":"Pancreatic Neuroendocrine Tumor pT1 TNM Finding v8","ValueMeaning":{"publicId":"6680057","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pT1 TNM Finding v8","longName":"6680057","preferredDefinition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring less than 2 cm. Limited to the pancreas means there is no invasion of adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery). Extension of tumor into peripancreatic adipose tissue is not a basis for staging. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pT1 TNM Finding v8","conceptCode":"C135552","definition":"Pancreatic neuroendocrine tumor limited to the pancreas and measuring less than 2 cm. Limited to the pancreas means there is no invasion of adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery). Extension of tumor into peripancreatic adipose tissue is not a basis for staging. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DDE3-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849CC52A-DDFC-3313-E053-F662850A9A54","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"TX","valueDescription":"Pancreatic Neuroendocrine Tumor pTX TNM Finding v8","ValueMeaning":{"publicId":"6680059","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pTX TNM Finding v8","longName":"6680059","preferredDefinition":"Pancreatic neuroendocrine tumor in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pTX TNM Finding v8","conceptCode":"C135551","definition":"Pancreatic neuroendocrine tumor in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DE09-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849CC52A-DE22-3313-E053-F662850A9A54","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6680048","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to well-differentiated neuroendocrine tumors arising in the pancreas. It does not apply to carcinomas of the pancreas, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C135536:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor TNM Finding v8","conceptCode":"C135536","definition":"A finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to well-differentiated neuroendocrine tumors arising in the pancreas. It does not apply to carcinomas of the pancreas, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849CC52A-DD44-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"849CC52A-DD55-3313-E053-F662850A9A54","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 3/21/19 curated for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506114","version":"1","longName":"Pancreas","context":"MCL","ClassificationSchemeItems":[{"publicId":"5854655","version":"1","longName":"Pancreas Core","context":"MCL"},{"publicId":"7781144","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000091","version":"1","longName":"Pancreatic","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001793","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"neuroendocrine_clinical_T_AJCC_8","type":"MCL Alt Name","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Clinical T category","type":"Preferred Question Text","description":"Clinical T category","url":null,"context":"NCI Standards"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Neuroendocrine Clinical T","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"pancreas_v0-1_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"849E6620-03C9-73A0-E053-F662850AF020","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"COLBERTM","dateModified":"2021-09-16","changeDescription":"8/17/21 mr Added Alt Name and Ref Doc to match MCL DD.   5-3-19 released; tmt. 3/21/19 curated for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}